Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
DANTRIUM (dantrolene sodium) 25mg capsules [Norgine]
Section 19A approved medicine
DANTRIUM (dantrolene sodium) 25mg capsules [Norgine]
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 008 422 348
Phone
1800 675 229
Approved until
Status
Current
Medicines in short supply/unavailable
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle - ARTG 42975
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle - ARTG 42976
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle - ARTG 42976
Indication(s)
Dantrium capsules are indicated for the treatment of chronic, severe spasticity of skeletal muscle in adults.
Additional information
Images
![Picture of Dantrium (dantrolene) capsules [Norgine] - bottle label](/sites/default/files/styles/full_lg_hi/public/2024-02/dantrium-dantolene-sodium-25mg-capsules-carton.png?itok=MPaaowku)